Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28595196 | 0.95 | ALDH1A1 (0.31) | ALDH1A1LMNA | |
| SCHEMBL28596194 | 0.95 | ALDH1A1 (0.31) | ALDH1A1LMNA | |
| SCHEMBL28116558 | 0.91 | — | — | |
| SCHEMBL838012 | 0.74 | — | — | |
| SCHEMBL2022165 | 0.71 | TSHR (0.37) | — | |
| SCHEMBL13453130 | 0.70 | — | — | |
| SCHEMBL838349 | 0.70 | — | — | |
| SCHEMBL506475 | 0.70 | — | — | |
| SCHEMBL1727635 | 0.67 | — | — | |
| SCHEMBL2098831 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1894 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117402275-B | Metallocene catalyst and preparation method thereof | 中国石油天然气股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| US-20250325575-A2 | SYNTHESIS OF 3 -RNA OLIGONUCLEOTIDES | ALNYLAM PHARMACEUTICALS, INC. (US) | 2025-10-23 | — | — | US | claimed |
| EP-4146636-B1 | SYNTHESIS OF VINYLIC PROTECTED ALCOHOL INTERMEDIATES | AMGEN INC (US) | 2025-06-11 | — | — | EP | claimed |
| CN-118725573-B | Dissolved oxygen fluorescent chemical sensing material and preparation and application thereof | 东华大学 | 2025-05-16 | — | — | CN | claimed |
| CN-119775747-A | Resin material, connector and photovoltaic module | 天合光能股份有限公司 | 2025-04-08 | — | — | CN | claimed |
| CN-119307030-A | Photovoltaic cable and preparation method thereof | 天合光能股份有限公司 | 2025-01-14 | — | — | CN | claimed |
| WO-2024200864-A1 | METHOD FOR THE SYNTHETIC CLEANING OF PEPTIDES WITHOUT HPLC | Technische Universität Berlin (DE) | 2024-10-03 | — | — | WO | claimed |
| CN-118725573-A | Dissolved oxygen fluorescent chemical sensing material and preparation and application thereof | 东华大学 | 2024-10-01 | — | — | CN | claimed |
| CN-117645809-B | Composite coating and preparation method and application thereof | 天合光能股份有限公司 | 2024-09-24 | — | — | CN | claimed |
| EP-4373832-A1 | PROCESSES OF MAKING ONAPRISTONE AND INTERMEDIATES THEREOF | Context Biopharma Inc. (US) | 2024-05-29 | — | — | EP | claimed |
| US-5998464-A | 4-Oxa and 4-thia steroids | MERCK & CO., INC. (US) | 1999-12-07 | — | — | US | claimed |
| US-5817802-A | IN IONIZING MEDIUM WITH A TRIALKYLSILANE | MERCK & CO., INC. (US) | 1998-10-06 | — | — | US | claimed |
| US-5777134-A | 4-oxa and 4-thia steriods | MERCK & CO., INC. (US) | 1998-07-07 | — | — | US | claimed |
| US-5696266-A | HYDROGENATING DELTA-5-STEROIDAL ENELACTAM DISSOLVED IN SOLVENT IN PRESENCE OF RHODIUM CATALYST | MERCK & CO., INC. (US) | 1997-12-09 | — | — | US | claimed |
| US-5650523-A | REACTION IN SOLVENTS TO FORM HYDROXY GROUPS | MERCK & CO., INC. (US) | 1997-07-22 | — | — | US | claimed |
| US-5508397-A | Activated macrolactams | ABBOTT LABORATORIES (US) | 1996-04-16 | — | — | US | claimed |
| EP-0444888-B1 | Process for the desilylation of a 4-silyloxy-tetrahydro-pyran-2-one | MERCK & CO INC (US) | 1995-02-08 | — | — | EP | claimed |
| US-5359053-A | Nucleic acid probes having nucleoside residue; usable with stringent hybridization conditions | G. D. SEARLE & CO. (US) | 1994-10-25 | — | — | US | claimed |
| EP-0444888-A1 | Process for the desilylation of a 4-silyloxy-tetrahydro-pyran-2-one | MERCK & CO. INC. (US) | 1991-09-04 | — | — | EP | claimed |
| EP-0415901-A2 | Improved nucleic acid probes | MONSANTO COMPANY (US) | 1991-03-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325575-A2 | SYNTHESIS OF 3 -RNA OLIGONUCLEOTIDES | NSUN3, RNGTT, NSUN2 | ALDH1A1 3080/4885LMNA 1697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.